News

GPhA supports eighth annual National Prescription Drug Take-Back Day

BY Antoinette Alexander

WASHINGTON, D.C. — The Generic Pharmaceutical Association has announced its support of the U.S. Drug Enforcement Administration’s eighth annual National Prescription Drug Take-Back Day, taking place April 26 at local take-back sites across America.

The event is dedicated to the safe disposal of prescription medications and is the result of collaboration among local, state, federal and tribal law enforcement, community and industry partners.

“Patient safety is the generic pharmaceutical industry’s No. 1 priority. Take-Back Day helps remind Americans of the thousands of facilities available to them for collection of unused or expired medication. This is an important tool for helping curb prescription drug diversion, misuse or abuse,” stated Ralph Neas, president and CEO of the Generic Pharmaceutical Association. “It also is a time to remind patients that prescription medicines are meant to be used as directed by health providers. Making sure that patients adhere to physician and pharmacist instructions in taking medications is critical to patients’ health. It also plays an important role in avoiding the problems caused by accruing surplus medications at home.”

According to the DEA, last year 324 tons of expired and unwanted medications were returned for safe and proper disposal at the 5,683 take-back sites that were available in all 50 states, the District of Columbia, and U.S. territories. The combined results of the previous take-back days have removed more than 3.4 million pounds (1,733 tons) of medication from circulation.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

McKesson Specialty Health’s new integrated inventory solution for ophthalmologists

BY Antoinette Alexander

THE WOODLANDS, Texas and SUMMIT, N.J. — McKesson Specialty Health has announced the integration of its distribution services with General Medical Services’ Physician Office Drug Inventory System, an alliance that creates the first end-to-end integrated inventory and order-to-reimbursement verification solution designed specifically for ophthalmologists.

“Drug inventory control has become an important aspect of ophthalmology practice management. As the leading inventory management solution provider in ophthalmology, we are excited to offer this unique solution with McKesson Specialty Health. For the first time, ophthalmology providers have seamless access to a full spectrum of specialty drugs through an optimized system that tracks each dose from order to payment receipt, taking drug management to new levels of performance. We are confident this will result in overall cost savings to the practice,” stated GMS CEO Steven Madreperla.

Benefits of the new integrated inventory solution include:

  • Ordering and distribution services for specialty drugs;
  • Order accuracy and on-time drug delivery;
  • Product integrity and quality;
  • Exemplary customer service; and
  • Competitive pricing.

 
An automated inventory management and payment verification system that provides:

  • Increased efficiency with automated ordering functionality, including split lot orders;
  • Real-time order tracking and direct payment;
  • Charge capture, billing accuracy and payment verification with complete process transparency; and
  • Reduced administration time.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Coca-Cola names Waller as new CFO

BY Ryan Chavis

ATLANTA — The Coca-Cola Co. on Thursday announced that its board of directors elected Kathy N. Waller as EVP and CFO, effective immediately. Waller is replacing Gary Fayard, who is retiring after 20 years with the company.

Waller most recently served as VP, Finance and Controller. She joined the company in 1987 as a senior accountant in the accounting research department and went on to assume roles of increasing responsibility. In addition to her role in finance, Waller leads the company’s Women’s Leadership Council. She also serves on the advisory board of Catalyst, a nonprofit organization with a mission to provide more opportunities for women and business.

Prior to joining Coca-Cola, Waller worked for Deloitte. She received her bachelor’s and MBA degrees from the University of Rochester in New York and is a certified public accountant.

The board also elected Larry M. Mark, Mark Randazza, Dr. Wamwari Waichungo, Ronald J. Lewis and Jos Wellekens as vice presidents of the company, effective immediately.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES